Martin is in charge to build Sanofi’s Global Generic portfolio and to manage global drug product development programs until launch. Since he joined Sanofi / Zentiva in 2012, he has worked in various roles in commercial operations and industrial affairs.
Martin has started his industrial career at Sandoz in 2002, where he held several positions in API development and portfolio management. From 2014 to 2015, Martin was responsible for the European business development of Glenmark.
Martin is Austrian and holds a PhD in organic chemistry from the technical university Graz, Austria.